- Home
- TARS vs BBT Comparison
TARS vs BBT Comparison
Compare TARS & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARS | BBT |
|---|---|---|
| Founded | 2016 | 1846 |
| Country | United States | United States |
| Employees | N/A | 2050 |
| Industry | Medicinal Chemicals and Botanical Products | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARS | BBT |
|---|---|---|
| Price | $58.46 | $30.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $89.00 | $33.25 |
| AVG Volume (30 Days) | ★ 1.4M | 763.8K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $56.43 | $77.88 |
| Revenue Next Year | $30.19 | $4.31 |
| P/E Ratio | ★ N/A | $29.98 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $22.81 |
| 52 Week High | $85.25 | $32.83 |
Technical Indicators
Market Signals| Indicator | TARS | BBT |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 51.27 |
| Support Level | $56.05 | $29.17 |
| Resistance Level | $67.14 | $30.59 |
| Average True Range (ATR) | 3.54 | 0.64 |
| MACD | -0.35 | -0.06 |
| Stochastic Oscillator | 23.72 | 63.36 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
About BBT Beacon Financial Corporation
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.